A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database-Reference-Cited by-同舟云学术

A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database

Published:2018-11-27 Issue:12 Volume:17 Page:1161-1169
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Carnovale Carla¹,Mazhar Faizan¹,Pozzi Marco²,Gentili Marta¹,Clementi Emilio¹²,Radice Sonia¹

Affiliation:

1. Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences L. Sacco, “Luigi Sacco” University Hospital, Università di Milano, Milan, Italy

2. Scientific Institute IRCCS Eugenio Medea, Lecco, Italy

Funder

Agenzia Italiana del Farmaco, Ministero della Salute, Regione Lombardia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2018.1550069

Reference55 articles.

1. Adverse Drug Events in Ambulatory Care

2. Avery AA, Barber N, Ghaleb M, et al. Investigating the prevalence and causes of prescribing errors in general practice: the practice study. General Medical Council; May 2 2012 [cited 2018 May 29]. Available from: https://www.gmc-uk.org/-/media/about/investigatingtheprevalenceandcausesofprescribingerrorsingeneralpracticethepracticestudyreoprtmay2012.pdf?la=en&hash=62C1821CA5CCC5A4868B86A83FEDE14283686C29

3. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review

4. World Health Organization. World alliance for patient safety: WHO draft guidelines for adverse event reporting and learning systems: from information to action. Geneva: World Health Organization; 2005 [cited 2018 May 29]. Available from: http://www.who.int/iris/handle/10665/69797

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study;Frontiers in Pharmacology;2024-09-06

2. Adverse events associated with SARS-CoV-2 neutralizing monoclonal antibodies using the FDA adverse event reporting system database;Toxicological Research;2024-07-30

3. The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system;Frontiers in Pharmacology;2024-07-10

4. Medication errors in older patients: a pharmacovigilance perspective;Drugs & Therapy Perspectives;2024-07

5. Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis;BioDrugs;2024-06-14